Skip to main content
SpringerLink
Log in

Use of the Albumin/Creatinine Ratio in Patient Care and Clinical Studies

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

Abstract

In patients with diabetes, elevated urinary albumin excretion (UAE) indicates the existence of functional as well as morphological abnormalities in the kidney [1–3]. Therefore, measurement of UAE is used for the early diagnosis of diabetic kidney disease as well as for monitoring its natural course and the effectiveness of treatment. Quantitative and semiquantitative methods are used to measure UAE.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hostetter TH, Rennke HG, Brenner BM. The case of intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72:375–380.

    Article  PubMed  CAS  Google Scholar 

  2. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM. Urinary albumin excretion as a predictor of renal structure in type I diabetic patients without overt proteinuria. N Engl J Med 1989; 320:966–970.

    Article  PubMed  CAS  Google Scholar 

  3. Walker JD, Close CF, Jones SL, et al. Glomerular structure in type I (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 1992; 41:741–748.

    Article  PubMed  CAS  Google Scholar 

  4. Mogensen CE. Urinary albumin excretion in early and long term juvenile diabetes. Scand J Clin Lab Invest 1971; 28:183–193.

    Article  PubMed  CAS  Google Scholar 

  5. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31:673–89.

    Article  PubMed  CAS  Google Scholar 

  6. Ginsberg JM, Chang BS, Maltarese RA, Garella S. Use of single-voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983; 309:1543–1546.

    Article  PubMed  CAS  Google Scholar 

  7. Nathan D, Rosenbaum C, Protasowiski D. Single void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 1987; 10:414–418.

    Article  PubMed  CAS  Google Scholar 

  8. Dunn PJ, Jury DR. Random urine albumin.creatinine ratio measurments as a screening test for diabetic microalbuminuria-a five year follow-up. N Z Med J 1990; 103:562–564

    PubMed  CAS  Google Scholar 

  9. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996; 7:930–937.

    PubMed  CAS  Google Scholar 

  10. Watts GF, Kubal C, Chinn S. Long-term variability of overnight albumin excretion in insulin-dependent diabetes mellitus: Some practical recommendations for monitoring microalbuminuria. Diabetes Res Clin Pract 1990; 9:169–177.

    Article  PubMed  CAS  Google Scholar 

  11. Jensen JE, Nielsen SH, Foged L, Holmegaaard SN, Magid E. The M1CRAL test for diabetic microalbuminuria: predictive values as a function of prevalence. Scand J Clin Invest 1996; 56:117–122.

    Article  PubMed  CAS  Google Scholar 

  12. Pegoraro A, Singh A, Bakir AA, Arruda AL, Dunea G. Simplified screening for microalbuminuria. Ann Intern Med 1997; 127:817–819.

    Article  PubMed  CAS  Google Scholar 

  13. Cohen SE, Warram JH, Hanna LS, Laffel L, Krolewski AS. Threshold effect of hyperglycemia on the progression of microalbuminuria in type I diabetes. J Am Soc Neph 1997; 8:109A (abstract).

    Google Scholar 

  14. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. New Engl J Med 1993; 329:1456–1462.

    Article  PubMed  CAS  Google Scholar 

  15. Viberti GC, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group. Effect of Captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271:275–279.

    Article  PubMed  CAS  Google Scholar 

  16. Laffel LMB, McGill JB, Gans DJ, on behalf of the North American Microalbuminuria Study Group. The beneficial effect of angiotensin-converting enzyme inhibition with Captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995; 99:497–504.

    Article  PubMed  CAS  Google Scholar 

  17. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118:128–138,1993.

    Article  Google Scholar 

  18. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Aim Intern Med 1993; 118:577–581.

    Article  CAS  Google Scholar 

  19. Morrison AS. Screening in chronic disease. New York, Oxford University Press, 1992, pp 1–20.

    Google Scholar 

  20. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendation to the scientific advisory board of the nNational Kidney Foundation from and ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kid Dis 1995; 25:107–112.

    Article  PubMed  CAS  Google Scholar 

  21. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346:1080–1084.

    Article  PubMed  CAS  Google Scholar 

  22. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycated hemoglobin and risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. New Engl J Med 1995; 332:1251–1255.

    Article  PubMed  CAS  Google Scholar 

  23. Connell SJ, Hollis S, Tieszen KL, McMurray JR, Doman TL. Gender and the clinical usefulness of the albumin:creatinine ratio. Diabetic Med; 11:32–6,1994.

    Article  PubMed  CAS  Google Scholar 

  24. Vestbo E, Damsgaard EM, Froland A, Mogensen CE. Urinary Albumin excretion in a population based cohort. Diabet Med 1995; 12:488–493.

    Article  PubMed  CAS  Google Scholar 

  25. Siegel JE, Krolewski AS, Warram JH, Weinstein MC. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Neph 1992; 3:S111–S119.

    Google Scholar 

  26. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1:1430–1432.

    Article  PubMed  CAS  Google Scholar 

  27. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. New Engl J Med 1984; 311:89–93.

    Article  PubMed  CAS  Google Scholar 

  28. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in Type (insulin-dependent) diabetes. Diabetologia 1984; 26:406–410.

    Article  PubMed  CAS  Google Scholar 

  29. Bach LA, Gilbert RE, Cooper ME, Tsalamandris C, Jerums G. Prediction of persistent microalbuminuria in patients with diabetes mellitus. J Diab Comp 1993; 7:67–72.

    Article  CAS  Google Scholar 

  30. Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T. The predictive value of microalbuminuria in IDDM Diabetes Care 1994; 17:120–125.

    Article  PubMed  CAS  Google Scholar 

  31. Forsblom CM, Groop PH, Ekstrand A, Groop LC. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ 1992; 305:1051–1053.

    Article  PubMed  CAS  Google Scholar 

  32. Janner M, Knill SE, Diem P, Zuppinger KA, Mullis PE. Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective logitudinal study. Eur J Pediatr 1994; 153:403–408.

    Article  PubMed  CAS  Google Scholar 

  33. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 1989; 12:686–693.

    Article  PubMed  CAS  Google Scholar 

  34. Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage reanl disease in IDDM: a 35 year follow-up study. Kidney Int 1996; 50:2041–2046.

    Article  PubMed  CAS  Google Scholar 

  35. Rudberg S, Ullman E, Dahlquist G. Relationship between early metabolic control and the development of microalbuminuria — a longitudinal study in children with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36:1309–1314.

    Article  PubMed  CAS  Google Scholar 

  36. Stephenson JM, Fuller JH. Microalbuminuria is not rare before 5 years of IDDM. J Diab & Comp 1994; 8:166–173.

    Article  CAS  Google Scholar 

  37. Orchard TJ, Dorman JS, Maser RE, et al. Pittsburgh epidemiology of diabetes complications study. II. Prevalence of complications in IDDM by sex and duration. Diabetes 1990; 39:1116–1124.

    Article  PubMed  CAS  Google Scholar 

  38. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25:496–501.

    Article  PubMed  CAS  Google Scholar 

  39. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in Type 1 diabetes Am J Med 1989; 78:785–794.

    Article  Google Scholar 

  40. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC. Albuminuria in Type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989; 32:870–876.

    Article  PubMed  CAS  Google Scholar 

  41. Pugia MJ, Lott JA, Clark LW, Parker DR, Wallace JF, Willis TW. Comparison of urine dipsticks with quantitative methods for microalbuminuria. Eur J Clin Chem CLin Biochem 1997; 35:693–700.

    PubMed  CAS  Google Scholar 

  42. Poulsen PL, Mogensen CE. Clinical evaluation of a test for immediate and quantitative determination of urinary albumin-to-creatinine ratio. Diabetes Care 1998; 21:97–98.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section on Genetics and Epidemiology Joslin Diabetes Center, Boston, Massachusetts, USA

    James H. Warram MD, ScD & Andrzej S. Krolewski MD, PhD

Authors
  1. James H. Warram MD, ScD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrzej S. Krolewski MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology), Aarhus Kommunehospital, Aarhus University Hospital, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Warram, J.H., Krolewski, A.S. (1998). Use of the Albumin/Creatinine Ratio in Patient Care and Clinical Studies. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6752-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6752-0_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6754-4

  • Online ISBN: 978-1-4757-6752-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation